This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Health Care

Gilead Sciences: A Preview of Important HIV Drug Study Results

Gilead Sciences: A Preview of Important HIV Drug Study Results

  • Tickers in this article:
  • GILD

Gilead's goal is to create new versions of its blockbuster HIV combination therapies, replacing Viread with TAF.

09/22/14 - 12:44 PM EDT

Northwest Bio's Almost-Toxic Debt Raise Responsible for Stock Slide

  • Tickers in this article:
  • NWBO

The buyers of Northwest's debt want the stock price to decline before Feb. 15, 2015, because a lower stock price also will drop the conversion price of the notes.

09/22/14 - 08:59 AM EDT

Try Jim Cramer's Action Alerts PLUS
Germany's Merck to Acquire St. Louis Chemical Firm Sigma Aldrich

Germany's Merck to Acquire St. Louis Chemical Firm Sigma Aldrich

German drug company Merck says it has agreed to buy St. Louis-based chemical firm Sigma-Aldrich for $17 billion.

09/22/14 - 07:26 AM EDT

Imprimis CEO: 'Dropless' Cataract Surgery Spurring Stock Interest

  • Tickers in this article:
  • IMMY

Shares of Imprimis Pharmaceuticals have more than doubled year-to-date because of strong interest in its 'dropless' cataract surgery, said the company's CEO Mark Baum.

09/19/14 - 10:35 AM EDT

Safety Worries Over Celgene's Experimental Crohn's Drug Overblown

Safety Worries Over Celgene's Experimental Crohn's Drug Overblown

  • Tickers in this article:
  • CELG

The first public presentation of the GED-031 phase II data will be on Oct. 21 at a European medical conference.

09/17/14 - 08:26 AM EDT

September 17 Premarket Briefing: 10 Things You Should Know

September 17 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are mixed; a rates announcement from the Federal Reserve is expected Wednesday afternoon; Trian launches campaign to break up DuPont; Endo makes bid for Auxilium.

09/17/14 - 06:56 AM EDT

Sodastream in Talks to Sell Itself, Health & Wellness Concept in Focus

  • Tickers in this article:
  • SODA

The Israeli company is reportedly talking to a British investment firm about a buyout.

09/16/14 - 04:39 PM EDT

U.N.: Ebola Cases Double Every Three Weeks, More Aid Needed

The World Health Organization is warning that the number of Ebola cases in West Africa could double every three weeks.

09/16/14 - 12:26 PM EDT

Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy

Doc Offers Glimpse Into Arena Pharma Weight-Loss Combination Therapy

Patients lost 12% of their body weight following 12 weeks of treatment with Arena's Belviq plus phentermine.

09/16/14 - 09:48 AM EDT

September 16 Premarket Briefing: 10 Things You Should Know

September 16 Premarket Briefing: 10 Things You Should Know

U.S. stock futures fall; the Federal Reserve begins a two-day meeting; Alibaba raises price range of its IPO; Boeing poised to get award to build space taxi, a report says.

09/16/14 - 06:51 AM EDT

United Rentals, Universal Health Services to be Added to S&P 500

Equipment lender United Rentals and hospital operator Universal Health Services will be added to the S&P 500 effective after the close of trading on Friday, September 19.

09/15/14 - 01:42 PM EDT

Cognizant Buys TriZetto for $2.7B, Seizing Opportunity for Growth

  • Tickers in this article:
  • CTSH

Cognizant Technology Solutions said it would buy private health care IT services company TriZetto for $2.7 billion in cash.

09/15/14 - 12:05 PM EDT

September 15 Premarket Briefing: 10 Things You Should Know

September 15 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are lower; Heineken rejects a takeover bid from rival SABMiller; Danaher to buy the Swiss dental-implant maker Nobel Biocare; Netflix expands further into Europe.

09/15/14 - 06:52 AM EDT

September 12 Premarket Briefing: 10 Things You Should Know

September 12 Premarket Briefing: 10 Things You Should Know

U.S. stock futures flat to slightly higher; Yahoo! was threatened with fines if it didn't turn over user data to U.S. government; HP is fined for bribery of Russian government.

09/12/14 - 06:54 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 17,172.68 -107.06 -0.62%
S&P 500 1,994.29 -16.11 -0.80%
NASDAQ 4,527.6890 -52.10 -1.14%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs